 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company, NASDAQ: GTH, a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the company will present at one of the ScienceAAAS Webinar Series, Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment. The webinar will be available o 